Filament Leads Market for Psychedelic Botanicals

Filament Health Announces Third Quarter 2024 Financial Results And Operational Highlights

These patients are considering MAiD. They say Canada has made it harder to access magic mushrooms — a treatment giving them reason to live

Innovative trial will use psilocybin to target relapse in opioid addiction